Literature DB >> 25287149

Noninvasive diagnostics supporting system for choroidal melanoma: a pilot study.

Ori Kameyama1, Yoshihiko Usui, Keisuke Kimura, Atsushi Nakamura, Takayuki Sota, Hiroshi Goto.   

Abstract

PURPOSE: To examine the usefulness of a near-infrared hyperspectral imager (NIR-HSI) system in discriminating uveal melanoma from other intraocular tumors.
METHOD: The NIR-HSI, which had been developed as a screening system for age-related macular degeneration, was used to measure near-infrared hyperspectral data (NIR-HSD) of a lesion located at the ocular fundus of 17 Japanese patients, including 5 with choroidal melanoma and 12 with other intraocular tumors. The index was derived from each NIR-HSD. Non-parametric statistical analysis was performed.
RESULTS: Diagnostic accuracy of 94.1% was achieved when the threshold value of the index was set to minimize the average value of false-positive and -negative fractions.
CONCLUSIONS: The NIR-HSI system is useful as a noninvasive diagnostic supporting system for choroidal melanoma.

Entities:  

Mesh:

Year:  2014        PMID: 25287149     DOI: 10.1007/s10384-014-0351-3

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  24 in total

1.  Hyperspectral imaging for measurement of oxygen saturation in the optic nerve head.

Authors:  Bahram Khoobehi; James M Beach; Hiroyuki Kawano
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-05       Impact factor: 4.799

2.  Biodistribution and dosimetry of N-isopropyl-p-[123I]iodoamphetamine in the primate.

Authors:  B L Holman; R E Zimmerman; J R Schapiro; M L Kaplan; A G Jones; T C Hill
Journal:  J Nucl Med       Date:  1983-10       Impact factor: 10.057

3.  Efficacy of (123)N-isopropyl-p-[(123)I]-iodoamphetamine single photon emission computed tomography for the diagnosis of uveal malignant melanoma.

Authors:  H Goto; M Usui; I Ishii
Journal:  Am J Ophthalmol       Date:  2001-12       Impact factor: 5.258

4.  Combination of clinical factors predictive of growth of small choroidal melanocytic tumors.

Authors:  C L Shields; J Cater; J A Shields; A D Singh; M C Santos; C Carvalho
Journal:  Arch Ophthalmol       Date:  2000-03

5.  A possible melanoma discrimination index based on hyperspectral data: a pilot study.

Authors:  Takashi Nagaoka; Atsushi Nakamura; Haruka Okutani; Yoshio Kiyohara; Takayuki Sota
Journal:  Skin Res Technol       Date:  2011-08-31       Impact factor: 2.365

6.  A sensitivity and specificity analysis of the surface microscopy features of invasive melanoma.

Authors:  S W Menzies; C Ingvar; W H McCarthy
Journal:  Melanoma Res       Date:  1996-02       Impact factor: 3.599

7.  Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features.

Authors:  S W Menzies; C Ingvar; K A Crotty; W H McCarthy
Journal:  Arch Dermatol       Date:  1996-10

8.  Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis.

Authors:  G Argenziano; G Fabbrocini; P Carli; V De Giorgi; E Sammarco; M Delfino
Journal:  Arch Dermatol       Date:  1998-12

9.  The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions.

Authors:  F Nachbar; W Stolz; T Merkle; A B Cognetta; T Vogt; M Landthaler; P Bilek; O Braun-Falco; G Plewig
Journal:  J Am Acad Dermatol       Date:  1994-04       Impact factor: 11.527

10.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

Authors: 
Journal:  J Am Coll Dent       Date:  2014
View more
  1 in total

1.  Hyperspectral Imaging and the Retina: Worth the Wave?

Authors:  Sophie Lemmens; Jan Van Eijgen; Karel Van Keer; Julie Jacob; Sinéad Moylett; Lies De Groef; Toon Vancraenendonck; Patrick De Boever; Ingeborg Stalmans
Journal:  Transl Vis Sci Technol       Date:  2020-08-05       Impact factor: 3.283

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.